Browse by Uncontrolled Keywords
Jump to: Article
Number of items: 3.
Article
Stout, JC;
Jones, R;
Labuschagne, I;
O'Regan, AM;
Say, MJ;
Dumas, EM;
Queller, S;
Justo, D;
Santos, RD;
Coleman, A;
+7 more...
Hart, EP;
Durr, A;
Leavitt, BR;
Roos, RA;
Langbehn, DR;
Tabrizi, SJ;
Frost, C;
(2012)
Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.
Journal of neurology, neurosurgery, and psychiatry, 83 (7).
pp. 687-694.
ISSN 0022-3050
DOI: https://doi.org/10.1136/jnnp-2011-301940
Tabrizi, SJ;
Reilmann, R;
Roos, RAC;
Durr, A;
Leavitt, B;
Owen, G;
Jones, R;
Johnson, H;
Craufurd, D;
Hicks, SL;
+8 more...
Kennard, C;
Landwehrmeyer, B;
Stout, JC;
Borowsky, B;
Scahill, RI;
Frost, C;
Langbehn, DR;
Investigators, T.-, H;
(2012)
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Lancet neurology, 11 (1).
pp. 42-53.
ISSN 1474-4422
DOI: https://doi.org/10.1016/S1474-4422(11)70263-0
Full text not available from this repository.
Tabrizi, SJ;
Scahill, RI;
Durr, A;
Roos, RAC;
Leavitt, BR;
Jones, R;
Landwehrmeyer, GB;
Fox, NC;
Johnson, H;
Hicks, SL;
+6 more...
Kennard, C;
Craufurd, D;
Frost, C;
Langbehn, DR;
Reilmann, R;
Stout, JC;
(2011)
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Lancet neurology, 10 (1).
pp. 31-42.
ISSN 1474-4422
DOI: https://doi.org/10.1016/S1474-4422(10)70276-3
Full text not available from this repository.